We leverage our mass spectrometry systems for absolute quantitation of protein biomarker panels.
Sapient’s quantitative proteomics approaches are ideal for targeted studies seeking greater insight into key proteins, including difficult-to-measure proteforms of interest.
Using our mass spectrometry-based methods, we annotate proteins and post-translational modifications (PTMs) from direct peptide measurement, achieving high analytical specificity.
Sapient’s targeted protein panels can be run on multiple matrices from cellular, preclinical, and clinical studies, and offer scalable multiplexing.
For questions or to discuss a specific project, we encourage you to book a time to talk to our scientific team.
"*" indicates required fields